Today: 20 October 2025
Subscribe
Tariffs & Rare-Earth Gold Rush: Cleveland-Cliffs Stock Surges 19% on New Trade Policies
 ·  ·  ·  · 

Tariffs & Rare-Earth Gold Rush: Cleveland-Cliffs Stock Surges 19% on New Trade Policies

by
20 October 2025
  • Q3 Results: Cleveland-Cliffs reported Q3 sales of $4.73 billion, up 3.6% from $4.57 billion a year ago [1], narrowly missing analysts’ $4.90 billion estimate.
  • Tariff-Driven Demand: The company cited President Trump’s 50% steel tariffs as reviving U.S. demand for its auto-grade steel [2]. CEO Lourenco Goncalves said, “As a result of this new trade environment, we have won new and growing supply arrangements with all major automotive [OEMs]” [3].
  • Rare-Earth Push: CLF announced plans to explore its Michigan and Minnesota mines for rare-earth minerals. Management noted this would “align Cleveland-Cliffs with the broader national strategy for critical material independence,” echoing the Biden administration’s push for domestic critical minerals [4] [5].
  • Stock Rally: CLF shares jumped ~19% premarket on Oct. 20 to about $15.87, settling around $15.50 (up ~16% intraday) [6] [7]. The stock has climbed roughly 42% YTD [8] after this surge.
  • Analyst Outlook: Despite today’s rally, analysts remain cautious. The consensus “Buy” rating comes with an average 12-month price target near $11.31 – about 27% below current levels [9]. Many see CLF as a beneficiary of tariffs, but warn that falling steel prices or demand could pressure profits ahead.

Tariff-Fueled Growth in Q3

Cleveland-Cliffs’ Q3 results revealed a tariff-fueled bump in sales. Revenue rose 3.6% year-over-year to $4.73 billion, thanks in part to the 50% tariff on imported steel imposed earlier this year [10]. The company shipped 4.0 million net tons of steel (vs 3.8 M last year), reflecting stronger orders from automakers [11]. However, CLF still posted a GAAP net loss of $251 million ($0.51/share), nearly unchanged from a year ago [12]. Adjusted loss was $0.45/share, in line with forecasts. Management emphasized that new long-term contracts with Detroit automakers (Ford, GM, etc.) were secured under the new trade rules. As CEO Goncalves noted, domestic demand has “recovered for automotive-grade steel made in the USA” thanks to the Trump administration’s “new trade environment” [13] [14]. In short, the tariffs are helping CLF grab market share at home.

Meanwhile, CLF also signed a memorandum of understanding (MOU) with a global steelmaker to leverage its U.S. capacity [15] [16]. The company reiterated cost-saving measures and trimmed its full-year outlook: it now expects 2025 capex of about $525 M (down from $600 M) and SG&A ~$550 M (down from $575 M) [17]. Such discipline is meant to preserve cash, especially since steel prices have started to moderate.

Rare-Earth Strategy Amid Trade Tensions

In a major strategic shift, Cleveland-Cliffs is betting on critical minerals too. The company announced it will explore for rare-earth elements (REEs) at its U.S. mining sites. This move comes as the U.S. government seeks to reduce dependence on China for REEs – essential for EVs, wind turbines and defense. Goncalves told investors that “the renewed importance of rare earths has driven us to re-focus on this potential opportunity at our upstream mining assets” [18]. He added that identifying REEs “align[s] Cleveland-Cliffs with the broader national strategy for critical material independence” [19].

This announcement coincides with a broader trade-rhetoric backdrop: earlier this month China tightened export controls on several rare-earth metals [20], prompting U.S. officials to consider even higher tariffs on Chinese goods in retaliation [21]. CLF’s push to find domestic REEs is therefore being viewed by investors as timely. (Other U.S. miners, like MP Materials, also jumped on the China news [22].) Cleveland-Cliffs’ exploration is in preliminary stages, but analysts say it could eventually add a new revenue stream if viable deposits are confirmed.

Stock Reaction and Analyst Take

Investors cheered the dual announcements. CLF stock spiked ~19% in premarket trading on Oct. 20 [23], and continued to trade near those levels during the day. At $15.50 (as of Oct. 20’s open [24]), the shares sit well above the average analyst target. Remarkably, this jump brought CLF to a roughly 41.7% gain year-to-date [25]. Market participants noted that CLF’s rally outpaced peers in steel and materials. For context, competitor Nucor (NUE) gained more modestly after reporting results, highlighting CLF’s unique tariff-and-REE narrative.

Despite the enthusiasm, Wall Street’s consensus remains cautious. According to StockAnalysis, the 11 covering analysts maintain a “Buy” consensus but with an average 1-year target of only $11.31 [26] (range $3.91 – $17.00). Several brokerages (JPMorgan, BofA, Wells Fargo) have “Hold” or modest “Buy” ratings, noting that CLF’s profits are still in the red and reliant on a favourable tariff regime. An analyst from Goldman Sachs recently reiterated a Strong Buy but only modestly raised his target from $13 to $15 [27].

Forecast: Many analysts expect CLF to remain volatile. If steel tariffs stay in place and global auto demand holds up, CLF could continue to outperform lower-cost or non-domestic producers. However, if tariffs are rolled back or if automotive production falters, the rally could lose steam. Given current sentiment and a full-year EBITDA forecast roughly flat to Q4, CLF’s short-term price target (consensus ~$12) likely lags the market price [28]. Still, some see room for the stock to stay elevated as long as the tariff-backed trading environment persists. Investors will be watching CLF’s next moves in capex, cost cuts and any concrete rare-earth findings, which Goncalves believes could be as transformative for critical minerals as past measures were for steel [29] [30].

Sources: Cleveland-Cliffs Q3 earnings release and related filings [31]; Dow Jones/WSJ coverage [32] [33]; Bloomberg Law (via Reuters) on rare-earth exploration [34]; trading commentary (Reuters/TS2/MarketScreener) on tariffs and stock movement [35] [36]; StockAnalysis (TipRanks) analyst data [37].

Bessent Floats Longer Tariff Truce for China Rare Earth Delay
Watch this video on YouTube.

References

1. www.marketscreener.com, 2. www.marketscreener.com, 3. www.marketscreener.com, 4. www.marketscreener.com, 5. news.bloomberglaw.com, 6. www.tradingview.com, 7. stockanalysis.com, 8. www.tradingview.com, 9. stockanalysis.com, 10. www.marketscreener.com, 11. investorshub.advfn.com, 12. www.marketscreener.com, 13. www.marketscreener.com, 14. investorshub.advfn.com, 15. www.marketscreener.com, 16. www.gurufocus.com, 17. www.tradingview.com, 18. news.bloomberglaw.com, 19. www.marketscreener.com, 20. ts2.tech, 21. ts2.tech, 22. ts2.tech, 23. www.tradingview.com, 24. stockanalysis.com, 25. www.tradingview.com, 26. stockanalysis.com, 27. stockanalysis.com, 28. stockanalysis.com, 29. www.marketscreener.com, 30. www.tradingview.com, 31. www.tradingview.com, 32. www.marketscreener.com, 33. www.marketscreener.com, 34. news.bloomberglaw.com, 35. ts2.tech, 36. www.tradingview.com, 37. stockanalysis.com

Tags:

Mateusz Kaczmarek Latest posts

A technology and finance expert writing for TS2.tech. He analyzes developments in satellites, telecommunications, and artificial intelligence, with a focus on their impact on global markets. Author of industry reports and market commentary, often cited in tech and business media. Passionate about innovation and the digital economy.

  1. Illinois Gas Bill Shock: Regulators Poised to Slash Record Utility Rate Hike Proposals
  2. Adobe’s AI Foundry Unveiled: Custom Brand AI Models and What Investors Are Saying
  3. What’s Driving American Water Works Stock Up ~4%? Key Facts and Insights
  4. Palantir Stock Skyrockets on Massive UK AI-Defense Pact – Could PLTR Eclipse Oracle by 2030?

Related Articles

Bit Digital (BTBT) Poised for Breakout as It Dumps Bitcoin Mining and Goes All-In on Ethereum
Previous Story

Bit Digital (BTBT) Poised for Breakout as It Dumps Bitcoin Mining and Goes All-In on Ethereum

Boeing Back in the Sky: FAA Approval and Jet Orders Lift BA Stock – What Analysts Say
Next Story

Boeing Back in the Sky: FAA Approval and Jet Orders Lift BA Stock – What Analysts Say

Stock Market Today

  • APA Corp Ex-Dividend Reminder: $0.25 Dividend, 4.44% Yield, Ex-Date 10/22/25
    October 20, 2025, 12:50 PM EDT. APA Corp (APA) is set to trade ex-dividend on 10/22/25, with a quarterly payout of $0.25 per share, payable 11/21/25. At a recent price near $22.5, the annualized yield sits around 4.44%. Expect the stock to drop roughly 1.1% on the ex-date, all else equal. The chart notes a 52-week range of $13.58-$25.83 and a last trade around $22.95, with APA down about 2.1% in Monday trading. While dividends are not guaranteed, the history can help gauge the likelihood of continued payouts. Investors should monitor the ex-date and any near-term price moves, as well as the broader market context that could influence shares ahead of the payment.
  • Dow Futures Tick Up as Cleveland-Cliffs Surges on Mixed Q3 2025 Results; Gold Climbs
    October 20, 2025, 12:38 PM EDT. Stock market activity edged higher as investors eyed a busy earnings week and signs of progress on U.S.-China talks. Dow futures rose about 0.28%, Nasdaq futures ~0.21%, and S&P 500 futures ~0.48%. Optimism was driven by stronger outlooks for Tesla and Netflix, easing concerns in regional banks, and a tentative thaw in trade tensions. Cleveland-Cliffs (CLF) jumped roughly 10.5% premarket after a Q3 2025 report showing an adjusted loss of $0.45 per share and revenue of $4.7B, supported by higher automotive-steel demand and a pivot to rare-earth minerals. CEO Lourenco Goncalves framed this as aligning with national diversification goals. Gold traded near $4,341/oz, up ~3%, while silver hovered near $52.8/oz amid risk demand.
  • Citius Oncology Secures McKesson Distribution for LYMPHIR Ahead of Q4 2025 Launch
    October 20, 2025, 12:36 PM EDT. Citius Oncology (CTOR) announced a distribution services agreement with McKesson to serve as authorized distributor of record for LYMPHIR (denileukin diftitox-cxdl). LYMPHIR is an FDA-approved immunotherapy for relapsed/refractory Stage I-III cutaneous T-cell lymphoma after prior systemic therapy. The deal completes Citius Oncology's core U.S. distribution network, aligning with all three largest pharmaceutical wholesalers, and sets the stage for a planned Q4 2025 commercial launch. McKesson's broad reach across hospitals, clinics, and pharmacies supports broad access to LYMPHIR, while additional steps (J-code assignment, NCCN guideline inclusion, provider/patient education, inventory readiness) bolster market readiness and potential near-term catalysts for the stock.
  • Stock Markets Open Higher on Earnings and China Trade Hopes
    October 20, 2025, 12:34 PM EDT. Stock markets opened higher on earnings optimism and China trade prospects, even as a government shutdown and partisan stalemate keep headlines tense. Bespoke Investment Group notes the stalemate persists, but the markets appear indifferent to the political gridlock, bidding up early session levels anyway. The narrative shifts away from bank loan fears toward earnings and overseas trade signals, suggesting traders are looking past politics for direction. As results flow and China data filters through, risk sentiment remains cautious yet constructive, with the market treating political headlines as backdrop to corporate guidance and global developments.
  • Markets rally on tariff relief bets and Fed rate-cut expectations
    October 20, 2025, 12:32 PM EDT. Stock futures and global equities edged higher as traders mulled a lower tariff risk and the prospect of a Federal Reserve rate cut. S&P 500 futures rose 0.27% premarket, with Asia and Europe broadly higher after China GDP growth beat estimates and a new pro-stimulus government in Japan. A JPMorgan note suggested a ruling that makes tariffs illegal could materially lift equities, reversing tariff-driven drag. The Nikkei 225 jumped 3.37% on Japan's coalition, while the CSI 300 gained about 0.5% on resilient growth. Markets priced in continued easing, eyeing Friday's CPI report and bets for a 25bp cut next week, with some strategists flirting with a 50bp move in December though that remains unlikely. Bitcoin hovered near $111k as risk appetite firmed.
Go toTop